Information:
Fel:
ID
34339
Beskrivning
Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT01080768
Länk
https://clinicaltrials.gov/show/NCT01080768
Nyckelord
Versioner (1)
- 2019-01-16 2019-01-16 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
16 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Hypertension NCT01080768
Eligibility Hypertension NCT01080768
- StudyEvent: Eligibility
Similar models
Eligibility Hypertension NCT01080768
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
patients (male or female) with hypertension aged between 18-75 yrs.
boolean
ID.2
Item
patients not treated with amlodipine or no amlodipine in previous 1 year.
boolean
ID.3
Item
post-menopausal females
boolean
ID.4
Item
patients unable to switch from prior hypertensive medication.
boolean
ID.5
Item
severe hypertension.
boolean
ID.6
Item
pregnant or nursing females.
boolean
ID.7
Item
patients with type 1 or type 2 diabetes mellitus
boolean
ID.8
Item
history of immunodeficiency diseases, including a positive human immunodeficiency virus (hiv) (enzyme-linked immunosorbent assay [elisa] and western blot) test result.
boolean
ID.9
Item
a positive hepatitis b surface antigen (hbsag) or hepatitis c test result.
boolean
ID.10
Item
other protocol-defined inclusion/exclusion criteria are applied
boolean